Oppenheimer is acting as lead book running manager for the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on CUE: Cue Biopharma announces common stock, warrant offering, no amount given Cue Biopharma receives $12M upfront in CUE-501 license pact Cue Biopharma’s Strategic Focus and Financial Outlook Cue Biopharma reports Q4 EPS (13c), consensus (14c) Cue Biopharma Appoints Pasha Sarraf to Board Disclaimer & DisclosureReport an Issue
